Home > Resources > Infographics > Snapshot of the patient-centric trial landscape

Snapshot of the patient-centric trial landscape

October 24, 2019

The FDA issued final guidance on the use of patient-reported outcome measures in clinical trials and how sponsors can use these tools to support labeling claims. Since then, patient-centric trial activity has been fairly stable and consistent.

Spotlight

Amber Pharmacy

Amber Pharmacy, a wholly owned subsidiary of Hy-Vee, Inc., is a pioneer in the specialty pharmacy industry. We are headquartered in Omaha, Nebraska and also have pharmacies strategically located in Chicago, Dallas, and Philadelphia.

Other Infographics

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.